Skip to main content

SNDL

Stock
Consumer Staples
Beverages - Wineries & Distilleries

Performance overview

SNDL Price
Price Chart

Forward-looking statistics

Beta
0.85
Risk
54.96%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

sundial believes in health, happiness and personal well-being. our cannabis is carefully cultivated for modern consumers—people looking for a natural alternative that fits today's active lifestyles. we are a licensed cannabis producer based in alberta. we combine tried-and-true heartland farming with innovative horticultural techniques to grow a select range of cannabis strains. our focus is on consistency—a pure cannabis experience that our customers can trust and count on.

Company info

SectorConsumer Staples
IndustryBeverages - Wineries & Distilleries
Employees1K
Market cap$536.9M

Fundamentals

Enterprise value$174.7M
Revenue$681.9M
Revenue per employee
Profit margin-11.53%
Debt to equity13.45

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.30
Dividend per share
Revenue per share$3.52
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio

Macro factor sensitivity

Growth+0.5
Credit+6.6
Liquidity+2.8
Inflation-4.8
Commodities-1.4
Interest Rates-1.4

Valuation

Dividend yield0.00%
PEG Ratio41.79
Price to sales0.35
P/E Ratio41.79
Enterprise Value to Revenue0.26
Price to book0.29

Upcoming events

Next earnings dayMarch 18, 2025
Next dividend day
Ex. dividend day

News

SNDL Inc. (SNDL) Reports Q1 Loss, Misses Revenue Estimates

SNDL Inc. (SNDL) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.01 per share a year ago.

Zacks Investment Research (May 1, 2025)
Weed stocks pop as Biden backs marijuana reclassification

Cannabis stocks are rising after President Joe Biden publicly endorsed the Justice Department's recommendation to loosen restrictions on marijuana, reclassified from a Schedule I to a Schedule III drug. Poseidon Investment Management co-founder Emily Paxhia joins Market Domination to break down the news.

Yahoo Finance (May 16, 2024)
Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug

Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.

Fox Business (August 30, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free